Raymond Gilmartin
Raymond Gilmartin
Raymond V. Gilmartinis an American former business executive and an Adjunct Professor of Management Practice at the Harvard Business School...
fastest goal largest
Our goal is not to be just one of the largest pharmaceutical companies, but also to be one of the fastest growing,
telling
No, I'm not telling you that at all.
controls cost effects exchange general net offset selling
The unfavorable effects of inflation, net of price, and exchange were partially offset by cost controls and productivity improvements in manufacturing, selling and general and administrative expenses.
less looked within
After we looked at the data, within less than a week, we withdrew the drug voluntarily.
driven growth income overall quarter strong unit volume
Income growth for the quarter was driven by strong overall unit volume gains,
excellent smooth tenure transition
He's an excellent candidate. Dick's long tenure here at Merck will make this is a smooth transition process.
cash strong
very strong financially, with very strong cash flow.
action believe best interests serves taking
We are taking this action, because we believe it best serves the interests of patients,
beginning cycle product
We're beginning a whole new cycle of important product launches,